Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
181.5 NOK | +0.83% | +3.12% | -15.19% |
Apr. 25 | Transcript : Medistim ASA, Q1 2024 Earnings Call, Apr 25, 2024 | |
Apr. 24 | Medistim ASA Approves Dividend for the Year 2023, Payable on May 6, 2024 | CI |
Sales 2024 * | 539M 48.41M | Sales 2025 * | 563M 50.62M | Capitalization | 3.32B 299M |
---|---|---|---|---|---|
Net income 2024 * | 107M 9.62M | Net income 2025 * | 118M 10.61M | EV / Sales 2024 * | 6.03 x |
Net cash position 2024 * | 78M 7.01M | Net cash position 2025 * | 119M 10.7M | EV / Sales 2025 * | 5.69 x |
P/E ratio 2024 * |
30.9
x | P/E ratio 2025 * |
28.1
x | Employees | 151 |
Yield 2024 * |
2.48% | Yield 2025 * |
1.86% | Free-Float | 74.3% |
Latest transcript on Medistim ASA
1 day | +0.83% | ||
1 week | +3.12% | ||
Current month | -2.42% | ||
1 month | -2.42% | ||
3 months | -13.16% | ||
6 months | -4.22% | ||
Current year | -15.19% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 60 | 09-08-31 | |
Director of Finance/CFO | - | 00-12-31 | |
Anne Waaler
CTO | Chief Tech/Sci/R&D Officer | 68 | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 76 | 99-12-31 | |
Director/Board Member | 54 | 23-03-31 | |
Lars Rønn
BRD | Director/Board Member | 60 | 09-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 181.5 | +0.83% | 2,011 |
24-04-29 | 180 | +2.86% | 12,921 |
24-04-26 | 175 | +0.57% | 2,701 |
24-04-25 | 174 | -6.70% | 29,751 |
24-04-24 | 186.5 | +5.07% | 4,654 |
Real-time Oslo Bors, April 30, 2024 at 10:45 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.19% | 300M | |
+7.15% | 217B | |
+6.60% | 183B | |
+9.86% | 131B | |
+24.32% | 106B | |
-0.95% | 62.16B | |
+11.04% | 51.02B | |
+4.81% | 50.89B | |
-1.43% | 40.16B | |
+24.40% | 31.44B |
- Stock Market
- Equities
- MEDI Stock